Market analytics and operational performance indicators
144 - January 2, 2026
Rocket Lab officer Frank Klein to sell 100,000 shares (~$7M) via Form 144.
Brief
This Form 144 filing notifies of officer Frank Klein's proposed sale of 100,000 common shares acquired from RSU vesting. The sale, valued at $6.98M, is under a Rule 10b5-1 plan adopted 9/19/2025, with approximate date 1/2/2026. In past 3 months, Klein sold ~51k shares for ~$2.1M; routine liquidity for investors.
Detailed Brief
Rocket Lab Corporation officer Frank Klein filed Form 144 on 1/2/2026 to sell 100,000 shares of common stock on NASDAQ, with aggregate market value $6,976,000 (implying ~$69.76/share) amid 534M shares outstanding. Shares stem from RSU vesting on 11/22/2024, 9/15/2025, and 11/22/2025. The transaction relies on a Rule 10b5-1 trading plan from 9/19/2025, ensuring pre-planned execution without material non-public info. Recent sales by Klein: 41,782 shares on 11/24/2025 ($1.7M), and 4,736 shares twice on 11/26/2025 (~$399k total). This is standard for executives monetizing equity comp at Rocket Lab, a space launch firm focused on Electron and upcoming Neutron rockets, amid growth in small satellite deployments.
Key Telemetry
- • Frank Klein (officer) proposes selling 100,000 common shares ($6.98M value) on ~1/2/2026.
- • Shares from RSU vesting dates: 11/22/2024, 9/15/2025, 11/22/2025.
- • Rule 10b5-1 plan adopted 9/19/2025; no known material adverse info.
- • Past 3 months: Sold 51,254 shares for $2,097,131 total.
- • 0.019% of outstanding shares (534M).
Impact Vector
Routine 10b5-1 sale by Rocket Lab officer for liquidity from vested RSUs poses minimal near-term risk, as volume is tiny vs. 534M shares outstanding and pre-planned to avoid insider timing issues. No adverse signals; common in growth firms like RKLB. Investors should monitor aggregate insider selling trends or volume spikes, but focus remains on launch success, Neutron progress, and contracts amid competitive space sector.